首页> 外文期刊>Gut and Liver >The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma
【24h】

The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma

机译:骨膜素过度表达与微血管侵犯的结合与肝细胞癌预后不良有关

获取原文
           

摘要

Background/AimsPeriostin is an extracellular matrix protein and is known to be related to the metastatic potential and prognosis of cancer. However, few studies have investigated the expression level of periostin and its association with prognoses in hepatocellular carcinoma. Therefore, we analyzed periostin overexpression in hepatocellular carcinoma and its implication for prognoses.MethodsWe evaluated 149 patients who underwent surgical resection between 2006 and 2010. Tissue microarrays were constructed from hepatocellular carcinoma tissue and adjacent nontumor tissue, and immunohistochemistry was performed.ResultsA high periostin level was observed more frequently in cases of multiple tumors (odds ratio [OR], 2.826; 95% confidence interval [CI], 1.224 to 6.527; p=0.013), positive microvascular invasion (OR, 2.974; 95% CI, 1.431 to 6.181; p=0.003), and advanced stage disease (OR, 3.032; 95% CI, 1.424 to 6.452; p=0.003). Patients with high periostin expression had significantly (p=0.002) lower overall survival rates than those with low periostin expression (90.3%, 66.1%, and 56.2% vs 97.7%, 85.1%, and 77.5% at 1, 3, and 5 years).ConclusionsWe found that a combination of periostin overexpression and microvascular invasion in hepatocellular carcinoma was correlated with a poor prognosis and can be a good prognostic marker for hepatocellular carcinoma.
机译:背景/目的骨膜素是一种细胞外基质蛋白,已知与癌症的转移潜力和预后有关。但是,很少有研究调查骨膜素在肝细胞癌中的表达水平及其与预后的关系。因此,我们分析了肝细胞癌中骨膜素的过度表达及其对预后的影响。方法我们评估了149例2006年至2010年接受手术切除的患者。从肝细胞癌组织和邻近的非肿瘤组织中构建了组织芯片,​​并进行了免疫组织化学分析。结果高骨膜素水平多发性肿瘤(奇数比[OR]为2.826; 95%置信区间[CI]为1.224至6.527; p = 0.013)更常观察到微血管侵犯(OR为2.974; 95%CI为1.431至6.181) ; p = 0.003)和晚期疾病(OR,3.032; 95%CI,1.424至6.452; p = 0.003)。高骨膜素表达的患者的总生存率显着(p = 0.002)比低骨膜素表达的患者(90.3%,66.1%和56.2%,1、3、5年的97.7%,85.1%和77.5% )结论我们发现,肝细胞癌中骨膜素过表达和微血管浸润相结合,预后较差,可以作为肝细胞癌的良好预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号